Plains All American Pipeline, L.P. Total Cost of Revenue increased by 20.1% to $11.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.3%, from $10.52B to $11.49B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 1.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.28B | $10.07B | $11.76B | $12.79B | $15.32B | $13.07B | $12.00B | $11.32B | $10.54B | $11.11B | $10.97B | $10.92B | $11.84B | $11.54B | $11.08B | $10.52B | $9.76B | $10.59B | $9.57B | $11.49B |
| QoQ Change | — | +8.6% | +16.7% | +8.7% | +19.9% | -14.7% | -8.2% | -5.6% | -6.9% | +5.3% | -1.3% | -0.4% | +8.4% | -2.5% | -4.0% | -5.0% | -7.2% | +8.5% | -9.6% | +20.1% |
| YoY Change | — | — | — | — | +65.2% | +29.7% | +2.0% | -11.4% | -31.2% | -15.0% | -8.6% | -3.6% | +12.3% | +3.9% | +1.0% | -3.7% | -17.6% | -8.3% | -13.6% | +9.3% |